Local servicesU.S. scenario · USDIllustrative operating case
Med spa startup costs and financial model
An independent physician-owned U.S. medical aesthetics practice in a leased 2,000 sq ft second-generation suite with four private rooms. A full-time nurse practitioner and registered nurse deliver a defined non-surgical treatment menu within verified state-specific authority, while a paid physician owner provides clinical governance, consultations and management. One receptionist supports a five-day calendar. Neuromodulator injections, dermal filler, laser hair removal and nonablative skin treatments share one completed-treatment visit pool; modest skincare retail is ancillary. The case excludes surgery, IV therapy, weight-loss prescribing, insurance billing, ablative resurfacing and wet-spa amenities.
Capital to open
$650,000
$425,000–$950,000 by launch scope
Year 3 revenue
$1,404,000
Annual modeled sales
Year 3 EBITDA margin
16.6%
Before interest, tax and depreciation
Calculator break-even
Month 6
Monthly sensitivity; separate from annual path
Annual revenue and EBITDA use the annual forecast. Break-even uses a separate monthly calculator sensitivity; it does not establish when the annual forecast covers its costs.
This operating case allocates $650,000 to opening the business and forecasts $232,600 in Year 3 EBITDA. Payroll includes working-owner labor where applicable. These are planning assumptions; EBITDA is not cash available to the owner.
An editorial comparison of operating conditions, not a probability of success, a customer rating or a promise of returns. Read the evidence beside each assessment.
Weighted total
4.3 / 10
The total combines the five assessments below using the published weights.
New independent U.S. physician-owned medical aesthetics practice in a leased four-room 2,000 sq ft suite; two full-time licensed clinicians, a paid physician owner and receptionist; five-day completed-treatment calendar. Mature operations include paid owner labor and employer costs; no local patient-access advantage is assumed.
Barrier to entry
Higher means easier entry.
15% weight
3.0 / 10
Clinical ownership and authority, specialist staffing, device selection and a dedicated fit-out create a difficult opening path.
Evidence and assessment basis
Anchor 3: medical-practice access can be obtained by a suitably qualified owner but state-specific clinical approvals and extensive site/device commitments dominate this modeled format. California’s documented ownership restriction supports the qualification hurdle, not a nationwide rule. The second-generation site reduces construction exposure without removing medical authority, staffing or device obligations. No specific applicant eligibility is verified.
Sources support the underlying facts. The numerical assessment is an editorial judgment.
Competition
Higher means more favorable competitive conditions.
20% weight
4.0 / 10
Independent and chain providers offer comparable elective treatments, so clinical reputation and ordinary service differences still face price comparison.
Evidence and assessment basis
Anchor 4: the generic catchment is modeled as accessible but crowded, with chain and clinician-office substitutes. OVME’s promotional menu and SkinSpirit’s location-specific pricing illustrate competing offers rather than prove a particular city is saturated. No supported exclusive referral channel or durable niche permits a higher anchor; verify actual local supply and paid acquisition before opening.
Sources support the underlying facts. The numerical assessment is an editorial judgment.
Demand stability
Higher means more stable demand.
25% weight
5.0 / 10
Repeat aesthetic use supports a recurring baseline, but these elective purchases can be postponed and discounted.
Evidence and assessment basis
Anchor 5: AmSpa’s original 2024 survey recap reports repeat patients and an established visit market; it does not prove renewal probability or downturn resilience. The scenario assumes diverse self-pay patients across the year, with discretionary spending, procedure timing and promotion exposure. No national monthly seasonality pattern, contracted demand or local retention advantage is asserted.
Sources support the underlying facts. The numerical assessment is an editorial judgment.
Margin ceiling
Higher means greater supported operating-profit potential.
20% weight
5.0 / 10
The mature case pays clinical and owner labor and produces surplus, while price, product cost and staffing constraints remain material.
Evidence and assessment basis
Anchor 5: the authored mature scenario includes physician-owner remuneration, NP/RN/reception costs, employer load, medical supplies and ongoing overhead. At twelve daily completions and the chosen mix it covers the full operating base; ordinary price or product-cost pressure reduces the buffer, and a combined lower ticket, higher variable cost and overhead case turns negative. Device replacement and financing reduce practical cash potential beyond the pre-depreciation, pre-interest and pre-tax proxy. No vendor margin is adopted as a benchmark.
Sources support the underlying facts. The numerical assessment is an editorial judgment.
Owner dependency
Higher means less dependence on the owner's continuous involvement.
20% weight
4.0 / 10
Licensed staff deliver routine treatments, while the physician owner remains essential for clinical governance and ordinary management.
Evidence and assessment basis
Anchor 4: paid clinicians and reception perform routine work, but the twenty-hour physician-owner role retains assessment/clinical-control responsibilities and management availability across operating days. Twenty hours is planned labor time, not permission to be unavailable when law or patient care requires support. No fully funded alternate physician governance and general-management layer supports extended absence. Clinical authority and emergency cover need local verification.
Sources support the underlying facts. The numerical assessment is an editorial judgment.
Who pays you, and what for
Review the customer, offer and operating scope behind the numbers before adapting them to your own plan.
Patient decision
Patients choose elective non-surgical aesthetic treatment after appropriate assessment, eligibility and consent. Privacy, qualified delivery, follow-up and continuity matter alongside price.
Clinical business format
The modeled entity is physician-owned and the owner retains actual clinical governance. A medical-spa name or a rented signature does not establish lawful clinical control.
Sales unit
One completed primary treatment encounter is allocated once to the menu mix. Complimentary consultations, follow-up and non-treatment activity consume time without automatically adding treatment revenue.
Operating constraint
Qualified-person time, procedure authority and room/device availability jointly govern throughput. Spare rooms cannot replace an absent clinician or physician support.
Format
Physician-owned medical aesthetics practice; 2,000 sq ft leased suite
Revenue unit
One completed primary treatment visit, counted once
Physician governance, consultations and management; 20 hours per week assumed
Mature schedule
12 completed treatment visits per day; 5 days per week
Who are you actually bidding against?
National provider offers establish substitutes and price-comparison issues. The selected catchment still needs a documented like-for-like competitor and paid-demand assessment.
Local market assessment pending. The checklist below identifies research to complete; it is not a measured competitor sample.
Compare the questions across each row. Scroll the table horizontally on a small screen →
Competitor research checklist · no measured local sample
Offer to investigate
Compare like for like
Evidence to collect
Medical-spa chains
Ordinary and introductory treatment prices, clinician credentials, consultation and aftercare, packages and location access.
Equivalent procedure/unit definitions, net retained prices, follow-up terms and the actual local clinics.
Dermatology and plastic-surgery offices
Physician access, clinical reputation, treatment menu and continuity.
Local self-pay services, available appointment lead times and ordinary fees for comparable scope.
Independent medical aesthetics practices
Named clinicians, patient repeat use, ordinary pricing and availability.
Catchment supply and paid-demand evidence without assuming patients will switch for a promotion.
What supports the model, and what strains it
These are operating considerations for the scenario, not measured advantages over local competitors.
Potential strengths to validate
Defined earned-sales unit. The common treatment pool keeps service mix, prices and ancillary retail reconcilable without counting packages or combined services twice.
Restricted launch menu. A defined non-surgical menu limits initial devices and staffing complexity while preserving clinical prerequisites.
Paid governance and labor. The case includes owner remuneration, licensed staff and non-treatment time rather than manufacturing surplus from free clinical work.
Tradeoffs to plan around
Clinical access precedes premises. State-specific ownership, assessment and delegation rules can determine whether the intended business structure is possible.
Inventory and device exposure. Injectable purchases, expiry, service contracts and replacements create cash demands beyond the displayed operating result.
Discretionary competition. Repeat treatment is possible, but ordinary-price retention and contribution must survive promotions and alternatives.
Does this operating role fit you?
Evaluate the work you will do and the cost of replacing it. Review the owner responsibilities in the operating scope.
A fit to explore if you can…
A qualified physician owner prepared to retain actual clinical control and support appropriate patient assessment and escalation.
An active operator who can recruit and fund licensed staff, secure records and reliable follow-up.
A decision maker willing to validate retained prices and local repeat completions before extending device and lease commitments.
Reconsider the plan if you need…
A passive investor assuming a nominal medical director automatically authorizes the business.
An operator treating rooms, social-media leads or prepaid package receipts as guaranteed completed treatments.
A founder relying on unlicensed treatment delivery, aggressive clinical promises or free owner labor to reach the plan.
Where the $650,000 goes
Authored opening allocation for a second-generation four-room suite and a restricted medical aesthetics menu. The lower and higher scopes change fit-out condition, device acquisition, inventory and reserve within the same format. No contractor, distributor or insurer quote has been obtained. Confirm device indications, servicing, training, storage requirements and legal operating authority before purchase. The reserve is separate from fit-out contingency; no paid-product example budget has been imported.
Leasehold work, accessible clinical layout and utilities
$150,000
Laser and nonablative treatment equipment
$125,000
Treatment chairs, clinical storage and room equipment
$35,000
Reception, secure records, booking and IT setup
$25,000
Opening injectable products, supplies and skincare inventory
$55,000
Legal structure, permissions, deposits and insurance setup
$45,000
Recruiting, clinical training and launch preparation
$40,000
Protected working capital reserve
$175,000
TotalScenario range $425,000 – $950,000$650,000
Where does the money come from?
Price, daily volume and the operating calendar define this capacity scenario. Check the sold-unit definition in the operating scope.
Net sales per completed treatment visit$450.00per sold unit
×
Completed treatment visits per day12modeled daily volume
Allocate every delivered primary treatment once across neuromodulator, filler, laser hair-removal and nonablative skin categories; apply realized net prices and ancillary retail once. Match product use, refunds, eligibility and complete time blocks to each category. Prepaid packages remain separate cash and service obligations.
Seasonality and the opening ramp
No national monthly pattern is imposed. Test actual repeat intervals, holidays, promotion effects, booking completion and device downtime in the chosen catchment. Clinical suitability controls treatment timing; sales targets do not.
What does the revenue have to cover?
Year 3 annual amounts from the income statement. The bars use the same revenue scale; EBITDA is the residual after the three operating expense lines.
Year 3 revenue$1,404,000
Injectable products, treatment consumables, retail cost and payment fees$491,400
Physician owner, NP, RN and reception incl. employer costs$500,000
Premises, insurance, records, marketing and device maintenance$180,000
EBITDA$232,600
Working-owner pay belongs in payroll. Interest, income taxes, loan principal, replacement equipment and changes in working capital affect cash available for distributions.
Five-year view · scroll the income statement horizontally to compare every year →
Five-year forecast
Separately authored annual cases use 260 treatment days, daily completed visits of 8.5, 10.5, 12, 13 and 14, and realized net sales per visit of $430, $440, $450, $465 and $480. Fractional visit counts are annual daily averages. Sales-linked costs are 38%, 36%, 35%, 35% and 35% of sales. Staffing and overhead are phased explicitly; the paid physician owner is included. These are scenarios, not observed practice results. Prepaid packages are recognized through the same delivered visits. The monthly sensitivity uses 4.33 weeks and pays the complete mature roster from opening.
RevenueEBITDA
$950.3k
$1.2m
$1.4m
$1.6m
$1.7m
Year 1
EBITDA $-20.8k
Year 2
EBITDA $118.8k
Year 3
EBITDA $232.6k
Year 4
EBITDA $312.6k
Year 5
EBITDA $397.7k
Med Spa income statement · annual USD
Income statement
Year 1
Year 2
Year 3
Year 4
Year 5
Revenue
$950,300
$1,201,200
$1,404,000
$1,571,700
$1,747,200
Injectable products, treatment consumables, retail cost and payment fees
−$361,114
−$432,432
−$491,400
−$550,095
−$611,520
Physician owner, NP, RN and reception incl. employer costs
−$440,000
−$475,000
−$500,000
−$520,000
−$540,000
Premises, insurance, records, marketing and device maintenance
−$170,000
−$175,000
−$180,000
−$189,000
−$198,000
EBITDA
−$20,814
$118,768
$232,600
$312,605
$397,680
EBITDA margin
-2.2%
9.9%
16.6%
19.9%
22.8%
Annual forecast and monthly operating reconciliation
Annual revenue and EBITDA use the annual forecast. Break-even uses a separate monthly calculator sensitivity; it does not establish when the annual forecast covers its costs.
Original inputs · annual USD · whole-dollar rounding tolerance $5
Check
Annual forecast
Monthly calculator base
Year 1 revenue
$950,300
$1,081,418
Year 1 operating result
−$20,814
$22,917
Year 2 revenue
$1,201,200
$1,402,920
Year 2 operating result
$118,768
$231,894
Year 3 revenue
$1,404,000
$1,402,920
Year 3 operating result
$232,600
$231,894
Year 3 / full-volume annual revenue
$1,404,000
$1,402,920
Year 3 / full-volume annual operating result
$232,600
$231,894
Year 1 uses months 1–12, Year 2 months 13–24 and Year 3 months 25–36. Full-volume rows use mature monthly sales and operating result × 12. The calculator holds price, days, contribution and fixed costs constant; an annual price, staffing or cost change can explain a separate path. Sliders do not change this comparison. Neither column measures cash flow, owner distributions or payback. Agreement tests arithmetic, not demand or cash funding. Input basis.
Set the three inputs to your own plan. The ramp starts at 50.0% of mature volume and adds 5.0 percentage points a month.
Monthly revenue over the first 18 months. Darker bars clear the operating break-even line.
Operating break-even
Month 6
Revenue at maturity
$116,910 / mo
Break-even revenue
$87,180 / mo
Break-even volume
9 / day
Fixed costs
$56,667 / mo
Year 1 ramp revenue
$1,081,418
Year 1 ramp operating result
$22,917
Full-volume operating result
$19,325 / mo
Use the volume definition in the operating scope. This sensitivity keeps fixed costs and contribution margin constant; it does not rebuild the annual income statement. Operating break-even covers monthly fixed operating costs. It does not recover the opening investment.
Two numbers that decide the outcome
Price and daily throughput define the operating case. The range endpoints are sensitivity scenarios; test whether your location can support them.
Net sales per completed treatment visit
$350.00$550.00
$450.00
this model
Completed treatment visits per day
716
12
this model
What if the schedule is lighter, or fuller?
Only daily volume changes. All three cases keep the invoice at $450.00, the schedule at 5 days per week, fixed costs at $56,667 per month and contribution margin at 65.0%.
Lower throughput
Use the low end to test a thinner schedule.
Completed treatment visits per day
7
Mature monthly revenue
$68,198
Operating break-even
Not reached
Not reached in the 18-month ramp.
Base throughput
The current modeled daily schedule.
Completed treatment visits per day
12
Mature monthly revenue
$116,910
Operating break-even
Month 6
First month contribution covers fixed costs.
Higher throughput
Validate the operating capacity first.
Completed treatment visits per day
16
Mature monthly revenue
$155,880
Operating break-even
Month 3
First month contribution covers fixed costs.
Capital payback needs a cash-flow schedule. The current forecast has no cumulative cash balance after funding, taxes, debt principal and future capital spending. No payback date or lowest cash balance is reported.
What can go wrong, and what should you test?
Use these checks to challenge the operating assumptions before taking on commitments.
Ownership or delegation mismatch
The chosen entity, supervising arrangement or provider scope does not permit the advertised menu.
Check: Obtain state-specific legal and regulator review of ownership, assessment, prescribing, delegation, supervision and clinical control before commitments.
Patient harm or poor escalation
Inadequate qualification, consent, product controls or complication response harms patients and the practice.
Check: Use qualified clinicians, appropriate product labeling, documented clinical protocols, real physician support, insurance and emergency escalation.
Unfunded clinician absence
One missing clinician substantially reduces the deliverable treatment calendar.
Check: Verify qualified relief, physician availability and rescheduling protocols; do not use spare rooms as a substitute for staff.
Discounted mix reduces contribution
High reported tickets or package receipts hide acquisition cost, drug cost, refunds and long treatment blocks.
Check: Track earned net sales, actual product consumption and clinical time by primary treatment category.
Inventory and devices absorb cash
Expiry, supplier terms, maintenance or breakdown consume operating reserve.
Check: Control lots, expiry, storage, purchase timing, device service and replacement funding in a dated cash plan.
Fit-out consumes protected reserve
Site work or device upgrades exhaust cash needed for the opening clinical roster.
Check: Resolve scope and fixed quotes, distinguish project contingency from operating reserve, and reduce opening commitments when the plan cannot fund both.
What would invalidate this scenario?
Choose your own go/no-go thresholds before committing funds. The page does not establish a universal stop-loss rule.
Before entity and lease commitments
State-specific clinical ownership, authority, permitted use or insured menu is unresolved.
Before device purchase
Actual indications, staff competence, servicing, utilities and clinical governance are unconfirmed.
Before advertising the calendar
Named qualified staff and physician support cannot cover assessment, treatment, follow-up and escalation.
Before expanding packages
Outstanding credits and future clinically appropriate service obligations cannot be reconciled.
Before adding another device or location
Ordinary-price completed visits and full-cost contribution have not demonstrated the current scope.
What needs to be true before you proceed?
Treat this page as a starting case to verify. A favorable spreadsheet result is only useful when its price, capacity and cost assumptions can be supported.
Who actually owns and controls the medical practice in the selected state?
Which assessment, prescribing and delegation permissions apply to each treatment and provider?
Can the named weekly roster cover treatment, consultations, records and follow-up with qualified absence support?
What net price and product cost remain after promotions, refunds and wastage?
Can the proposed premises and devices be insured, maintained and funded without using the protected reserve?
What paid-demand and repeat-completion evidence would justify the lease or another device?
I would confirm lawful clinical access and the named paid clinician calendar before committing to a larger device menu. The investment depends on appropriate completed treatments, retained contribution and funded clinical support after the patient leaves the room.
Paid physician-owner governance and non-treatment time belong in the operating cost base. Two qualified clinicians create the treatment calendar; four rooms add flexibility without doubling delivery capacity, and one clinician’s absence can leave the remaining roster below the operating floor.
Product consumption and realized prices determine contribution before payroll. A high reported ticket does not establish surplus after injectable acquisition, wastage, qualified labor and ordinary overhead.
Inventory, device servicing and prepaid obligations can consume cash despite a mature operating surplus. Package receipts improve timing but create future service obligations rather than a second pool of treatment revenue.
What could change the view
Fixed clinical, site and device commitments are made before legal scope, ordinary-price eligible completions and product-level contribution support the staffed calendar.
Who this format suits
This format suits an active qualified physician owner who retains actual clinical control, funds licensed staff and reliable follow-up, maintains secure records and uses earned-sales and cash evidence to guide expansion.
Before committing
Obtain state-specific ownership and treatment-authority review, named paid staff commitments, timed clinical blocks, real device and supply quotes, and a dated inventory and prepaid-obligation cash plan before signing the lease.
Explore the online workbook illustration
This HTML illustration uses the website's scenario. The editable Excel product is sold separately; this view is not a screenshot or an inventory of its worksheets.
Med Spa · Operating assumptionsIllustrative layout
Scroll to read the worksheet →
Current model inputs · USD unless stated
Input
Model
Unit
Opening capital
$650,000
one-time
Net sales per completed treatment visit
$450.00
per sold unit
Completed treatment visits per day
12
per day
Operating schedule
5
days / week
Fixed operating costs
$56,667
per month
Contribution margin
65.0%
input assumption
The published calculator and annual forecast are separate views. The downloadable workbook requires its own separate calculation review.
Revenue
The current product page describes one shared visit pool, service-category allocation, prices, operating periods, seasonality and ancillary revenue once per visit.
This section describes the website scenario. It does not show a screenshot of the purchased workbook.
COGS & OPEX and Payroll
Product material identifies direct, variable and fixed operating costs, with payroll in the broader workbook. The online case explicitly funds clinical labor and owner governance.
This section describes the website scenario. It does not show a screenshot of the purchased workbook.
CAPEX and Capital
The product gallery identifies capital investment and funding sections for adapting site, device and opening cash requirements.
This section describes the website scenario. It does not show a screenshot of the purchased workbook.
Statements and Scenarios
The product page identifies five-year monthly and annual projections, income statement, cash flow, balance sheet, dashboard and low/base/high scenario reporting.
This section describes the website scenario. It does not show a screenshot of the purchased workbook.
Explore the separate editable Business Plan and Financial Model below. The online outlines describe this scenario; purchased files have their own examples.
Get the editable files
Word for the written plan. Excel for the assumptions and calculations. One-time prices in USD. Bundle adds both products to one cart.
Prepared online sections for a physician-owned medical aesthetics practice with paid clinical governance
One completed-treatment visit pool reconciled with menu mix, retained price and qualified-person capacity
Matching paid Word plan uses a broader premium, multiservice example; its staffing, device scope and optimistic financial assumptions require replacement
Confirm these items for your location and operating scope. This checklist does not assert that a particular license, insurance policy or employment arrangement is sufficient.
Legal and clinical access
Confirm actual entity ownership and clinical control.
Verify each provider’s license, competence and treatment-specific authority.
Document patient assessment, orders, supervision, escalation and insurance.
Site and equipment
Resolve permitted use, accessible layout and coordinated fit-out quotes.
Validate devices, supplier authenticity, training, storage and service arrangements.
Set infection-control, waste, records and stock procedures for the actual menu.
People and demand
Build named paid shifts with non-treatment time and qualified backup.
Collect local equivalent ordinary and introductory price evidence.
Test paid eligible treatment completions and repeat cohorts without assuming survey averages.
Cash and earned revenue
Reconcile product consumption and contribution by primary treatment.
Track package receipts, redemptions, refunds and outstanding obligations.
Fund payroll, debt, tax, device replacements and inventory payments in a dated cash schedule.
Where could this model miss your situation?
Most financial inputs are author-selected assumptions. The source register explains what is supported and what still needs local validation.
National case with a state example
The scenario is not a local license determination or legal opinion. California establishes one jurisdiction’s restrictions; the actual state and proposed entity require separate review.
Financial assumptions
No local lease, fit-out, device, drug, wage or insurance quote is verified. National wages and provider offers provide context rather than certify this budget or ticket.
Clinical capacity
Modeled time blocks are scheduling assumptions, not treatment instructions or clinical workload recommendations. Eligibility, individual protocols, skills and physician availability may bind first.
Separate annual and monthly views
Annual cases phase staffing and realized ticket. The monthly sensitivity pays the mature roster from opening and uses a different weeks convention; it is not a matching cash forecast.
Product adaptation and review
Seller descriptions establish the medical-aesthetics product scope. No paid-file formula audit, completed purchase, verified delivery or current human review of this planning package is claimed.
Extended analysis: editorial basis
Prepared from current cited sources and explicit authored assumptions for the stated U.S. med spa operating scope. The site owner reviewed and approved this AI-assisted planning case for publication on October 3, 2026. This review does not establish local fieldwork, clinical or legal approval, a purchased-file formula audit, payment or paid-file delivery.
Physician governance, consultations and management; 20 hours per week assumed
Mature schedule
12 completed treatment visits per day; 5 days per week
StartFigures models one independent physician-owned U.S. medical aesthetics practice. Official clinical, classification, workforce, infection-control and tax sources establish context; California provides a clearly bounded ownership and clinical-delivery example. Original industry survey and provider menu evidence supply market context, not local demand or model targets. All capital, price, mix, visit, staff, cost and ramp inputs are authored assumptions requiring local validation. The annual cases use 52 weeks; the separate monthly sensitivity uses 4.33 weeks and a full mature roster from opening. Sales exclude sales tax and unearned prepaid balances. The operating proxy includes paid physician-owner labor and excludes depreciation, financing, income tax, replacement capital and working-capital timing. The site owner reviewed and approved this AI-assisted planning case for publication on October 3, 2026. No local clinical approval, patient outcome, paid-file audit or investment return is implied.
U.S. Bureau of Labor Statistics · primary · accessed October 2, 2026
The occupation-specific May 2025 nurse practitioner median is $132,300; do not substitute the combined nurse-anesthetist, midwife and NP median. Supports wage context, not local availability, authorized scope or the chosen salary.
U.S. Bureau of Labor Statistics · primary · accessed October 2, 2026
May 2025 national median family-medicine physician wage of $244,180, licensing and work context. The owner salary, burden and roster are authored assumptions, not employer quotes or owner earnings data.
Centers for Disease Control and Prevention · primary · accessed October 2, 2026
Outpatient-relevant infection prevention responsibilities, written policies, staff training and safe systems. Supports operating cost categories, not quoted equipment costs or certification of this planned practice.
U.S. Department of Health and Human Services · primary · accessed October 2, 2026
Covered-provider and protected-health-information responsibilities. The modeled insurance-billing practice needs appropriate privacy systems; no EHR product or workflow is certified by this content.
Internal Revenue Service · primary · accessed September 28, 2026
Provides federal employer payroll-tax guidance. State taxes, benefits, workers' compensation, unemployment insurance, overtime and local employer costs require separate calculation.
Medical Board of California · primary · accessed October 2, 2026
California guidance treats medical-spa procedures as medical practice and addresses physician ownership and qualified clinical delivery. This is a California example, not a nationwide ownership or delegation rule, and does not establish that the proposed practice has approval.
U.S. Food and Drug Administration · primary · accessed October 2, 2026
Describes approved-use boundaries and serious filler risks, including unintended vascular injection. Supports clinical risk and preparedness discussion, not a treatment protocol, clinical outcome, procedure duration or financial assumption.
American Med Spa Association · industry · accessed October 2, 2026
Original survey recap reports 245 monthly visits, $527 average visit spending, 73% repeat patients and 10,488 U.S. medical spas for the reported period. Context only: not a 2026 local demand test, retention probability or revenue target for this case.
U.S. Bureau of Labor Statistics · primary · accessed October 2, 2026
Current page reports May 2025 national RN median pay of $97,550. Wage context excludes aesthetic specialization, employer burden and local recruiting availability; it does not authorize any treatment.
Current provider menu lists introductory starting prices including $9 per neuromodulator unit, $499 per filler syringe and $680 for nonablative MOXI. New-client terms and studio variation apply. These are vendor offers, not nationwide ordinary prices, doses or proof of the modeled realized ticket.
Provider explains that pricing varies with individual concerns and location. Supports like-for-like local competitor research and pricing limitations, not the specific forecast or an acquisition advantage.
The authored opening allocation is $650,000, including a $175,000 protected reserve. The $425,000 to $950,000 scope range changes fit-out condition, devices, inventory and reserve within a physician-owned four-room medical aesthetics practice. Obtain actual site, device, legal and insurance quotes before committing.
Is this the same business as a massage day spa?
No. This practice provides injections and selected laser or nonablative skin treatments through qualified medical personnel. It excludes ordinary massage-spa positioning, surgery, IV therapy, weight-loss prescribing, insurance billing and wet amenities. Its clinical ownership, assessment and delegation obligations differ from a non-medical spa.
Can anyone open a med spa by hiring a medical director?
Do not assume so. Entity ownership, corporate-practice restrictions, clinical control, prescribing and delegation vary by state. California’s Medical Board explicitly describes medical procedures as medical practice with physician-ownership requirements. This case assumes physician ownership; it does not establish that any proposed arrangement is lawful elsewhere.
What counts as a completed treatment visit?
One delivered, paid primary treatment encounter counted once. Complimentary consultation and follow-up capacity are recorded separately. If a combined-service encounter is added, give it one price, cost and time block rather than counting it twice. Net revenue excludes sales tax, refunds and unearned prepaid balances.
Does the forecast pay the owner and clinical staff?
Yes. Mature annual payroll includes the paid physician owner, NP, RN and receptionist, employer costs and a relief allowance. The owner’s assumed twenty-hour role includes governance, consultations and management, with no free treatments used to repair the base case.
Why can four rooms not produce four parallel treatment schedules?
Only two full-time clinicians supply the modeled treatment calendar. At the chosen mix, each visit uses a forty-two-minute complete clinical block. Consultations, follow-ups, skills, physician authority, maintenance and absence coverage can reduce capacity below a room-based calculation.
Is operating surplus owner income or investment payback?
No. The scenario includes paid owner labor but the operating proxy excludes depreciation, interest, principal payments, income tax, replacement investment and working-capital timing. Device purchases, stock expiry and prepaid-service obligations can use cash even when operations show a surplus.
Do the paid files use the exact online scenario?
No. The matching medical-spa Word and Excel products have editable examples. The current product material describes a shared-visit, service-mix and category-price revenue model with ancillary revenue once per visit. Their broader premium assumptions need adaptation to this scope; paid-file formulas and successful delivery were not independently tested.
Related business ideas
Compare the capital requirement and operating scope of another business.
